Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now indicates recruitment has ended ('No longer looking for participants'), adds user-help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new 'Intervention/Treatment' section, replaces the old 'Intervention / Treatment' heading, and updates the Revision tag from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check20 days agoChange DetectedThe page’s revision tag changed from v3.5.4 to v3.5.5, signaling a minor update to the ClinicalTrials.gov study page without changing the study content.SummaryDifference0.1%

- Check41 days agoChange DetectedA new Revision: v3.5.4 label was added for the Study Protocol and Statistical Analysis Plan, signaling an updated version of the document. The previous Revision: v3.5.3 label was removed (superseded).SummaryDifference0.1%

- Check55 days agoChange DetectedA new page revision v3.5.3 was added and the previous revision v3.5.2 was removed. This update documents a change to the page's versioning on the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision metadata updated to v3.5.2; the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This appears to be a site revision and does not modify the study details displayed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.